News Column

Genocea Co-Founder Named to Time Magazine's Time 100

May 4, 2014

Genocea Biosciences, a clinical-stage biopharmaceutical company, announced that Time magazine has named company co-founder David A. Sinclair, Ph.D., to the 2014 Time 100, its annual list of the 100 most influential people in the world.

According to a release, recognized for his breakthroughs in aging research, Dr. Sinclair currently serves as a Professor of Genetics and co-Director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School.

"The Genocea team extends warm congratulations to David on his recognition as a TIME 100 honoree," said Chip Clark, president and chief executive officer of Genocea. "David's inspired leadership formed the solid foundation upon which Genocea has grown into a thriving public company with two products in clinical development and a T cell antigen discovery platform with the potential to deliver vaccines and immunotherapies for a range of challenging diseases. Today we celebrate David's legacy at our organization along with his many other remarkable contributions to the medical field."

Dr. Sinclair's research focuses primarily on identifying ways to enhance the body's natural ability to cure diseases. His Harvard research team is working to uncover biological processes that translate into novel medicines to promote longer, healthier lives. A focus is on the Sirtuin genes and how they protect against aging and diseases such as infection, cancer, heart disease, inflammation, neurodegeneration and diabetes. Additionally, Dr. Sinclair is a co- joint Professor at the University of New South Wales in Sydney and co-founder and co-chief editor of the journal Aging. He obtained a Ph.D. in Molecular Genetics at the University of New South Wales, Sydney. Dr. Sinclair has published more than 125 scientific papers and filed 25 patents and is the 2014 Australian Society for Medical Research (ASMR) medalist, an award which recognizes his career contributions to medical research, and an honor shared by past Nobel Prize winners. He is also the co-founder of several biotechnology companies and is on the scientific advisory board of several others. Dr. Sinclair co-founded Genocea with Darren Higgins in 2006.

"I'm honored to join the TIME 100, a list that brings awareness to some of the exceptional work being conducted globally to improve quality of life in various ways," said Dr. Sinclair. "My colleagues at Genocea are making great strides with T cell technology in infectious diseases and immunotherapy, and I am proud to be a founding scientific partner."

The Time 100 list, now in its 11th year, recognizes the activism, innovation and achievement of the world's most influential individuals. The full list and related tributes appear in the May 5 issue of Time and at time.com/time100.

((Comments on this story may be sent to newsdesk@closeupmedia.com))


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Professional Services Close - Up


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters